Evidence map›Paper›PMID 32580297›Full record

ArticleMolecules (Basel, Switzerland)2020

Active Compound of

Jisu Song, Heejung Seo, Mi-Ryung Kim, Sang-Jae Lee, Sooncheol Ahn, Minjung Song

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jisu SongDepartment of Food Biotechnology, School of Medical and Life Science, Silla University, Busan 46958, Korea.
Heejung SeoDepartment of Food Biotechnology, School of Medical and Life Science, Silla University, Busan 46958, Korea.
Mi-Ryung KimDepartment of Food Biotechnology, School of Medical and Life Science, Silla University, Busan 46958, Korea.
Sang-Jae LeeDepartment of Food Biotechnology, School of Medical and Life Science, Silla University, Busan 46958, Korea.
Sooncheol AhnDepartment of Medical Science, School of Medicine, Pusan National University, Yangsan 50612, Korea.
Minjung SongDepartment of Food Biotechnology, School of Medical and Life Science, Silla University, Busan 46958, Korea.
Silla University · KRPusan National University · KRWellcome/MRC Institute of Metabolic Science · GB

Funding

National Research Foundation of Korea NRF-2013M3A9A5076603National Research Foundation of Korea NRF-2016R1A1A1A05921948National Research Foundation of Korea NRF-2016R1D1A1B03936183
6 · The paper itself

Abstract

Kirsten rat sarcoma viral oncogene homolog (KRAS)-driven colorectal cancer (CRC) is notorious to target with drugs and has shown ineffective treatment response. The seeds of

Indexed as

ApoptosisCell Line, TumorCell ProliferationChromatography, High Pressure LiquidColorectal NeoplasmsHumansIpomoea nilMuscle CellsMutationProto-Oncogene Proteins p21(ras)SeedsKRAS protein, humanProto-Oncogene Proteins p21(ras)colorectal cancerKRASmuscle functionPharbitis nil

Identifiers

PMID32580297
PMCPMC7356163
OpenAlexW3036538371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.